BIO-TECHNE CORP (TECH:NASDAQ)
$72.63 0.01 (0.0138%)
Analysed BIO-TECHNE CORP (TECH:NASDAQ) News Sources
Is Bio-Techne Stock Outperforming the Nasdaq?
24-09-2026
barchart.com
Winners And Losers Of Q2: Bio-Techne (NASDAQ:TECH) Vs The Rest Of The Research Tools & Consumables Stocks
31-08-2026
yahoo.com
Bio-Techne Achieves Science Based Targets Validation and Reports Significant Progress Toward Climate Goals
01-09-2026
yahoo.com
Bio Techne (TECH) And The Valuation Case Behind Its Recent Rebound
15-09-2026
yahoo.com
Bio-Techne Opens New Customer Experience Center in Düsseldorf to Accelerate Scientific Discovery and Customer Collaboration
22-09-2026
yahoo.com
Bio-Techne Shareholders Approve Acquisition by Merck KGaA, Darmstadt, Germany
23-09-2026
yahoo.com
2 Cash-Producing Stocks Worth Investigating and 1 We Brush Off
28-09-2026
yahoo.com
Bio-Techne Expands Global GMP Manufacturing Network with New Bristol Facility to Advance Scalable Cell Therapy Development
08-10-2026
yahoo.com
Bio-Techne opens GMP small molecule facility in Bristol, UK
09-10-2026
pharmaceutical-technology.com
1 Unpopular Stock That Should Get More Attention and 2 We Question
09-10-2026
yahoo.com
What is the current price of BIO-TECHNE CORP (TECH:NASDAQ)?
The current price of BIO-TECHNE CORP (TECH:NASDAQ) is $72.63.
BIO-TECHNE CORP (TECH:NASDAQ) absolute price change since previous trading day?
The absolute price change of BIO-TECHNE CORP (TECH:NASDAQ) since the previous trading day is $0.01.
BIO-TECHNE CORP (TECH:NASDAQ) percentage price change since previous trading day?
The percentage price change of BIO-TECHNE CORP (TECH:NASDAQ) since the previous trading day is 0.0138%.
What is the most recent average sentiment score for BIO-TECHNE CORP (TECH:NASDAQ)?
The most recent average sentiment score for BIO-TECHNE CORP (TECH:NASDAQ) is 60 out of 100.
What is the most recent average sentiment for BIO-TECHNE CORP (TECH:NASDAQ)?
The most recent sentiment for BIO-TECHNE CORP (TECH:NASDAQ) is .
SEC-8K** Filing Available For BIO-TECHNE CORP (TECH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.